Turn off MathJax
Article Contents
Yaping Zhou, Yitan Zou, Shaodong Lv, Dan Tan, Guangyao Li, Wenyan Fu, Changhai Lei, Mingdong Lu, Shi Hu. Antibody screening for tumor and immune hotspot targets: the frontier of new methods and technologies[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101417
Citation: Yaping Zhou, Yitan Zou, Shaodong Lv, Dan Tan, Guangyao Li, Wenyan Fu, Changhai Lei, Mingdong Lu, Shi Hu. Antibody screening for tumor and immune hotspot targets: the frontier of new methods and technologies[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101417

Antibody screening for tumor and immune hotspot targets: the frontier of new methods and technologies

doi: 10.1016/j.jpha.2025.101417
  • Received Date: Oct. 24, 2024
  • Accepted Date: Jul. 25, 2025
  • Rev Recd Date: Jun. 25, 2025
  • Available Online: Jul. 29, 2025
  • Advancements in tumor immunotherapy highlight the significant potential of antibody drugs, a key category of biological agents, for treating cancer and autoimmune diseases. This paper begins by defining and classifying key targets in tumor immunity, as well as discussing their structural and functional characteristics. Subsequently, it elaborates on innovative technologies for antibody drug screening, which, when integrated with contemporary molecular biology, biotechnology, and computational biology, have substantially enhanced the efficiency and accuracy of target identification and antibody drug screening processes. Despite the promising prospects of tumor immunotherapy, certain limitations persist in its practical implementation. In conclusion, this paper offers a comprehensive examination of the cutting-edge developments in tumor immunotherapy, focusing on the aspects of tumor immunotherapy itself, critical targets for immunotherapy, and novel technologies and methodologies for antibody screening. This analysis is crucial for advancing the field of tumor immunotherapy and for enhancing both therapeutic efficacy and safety. Furthermore, research and development of antibody drugs in other domains, such as autoimmune and inflammatory diseases, can benefit from it.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (39) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return